Hyalex Orthopaedics receives FDA Breakthrough Device designation for cartilage repair system

Medical device company Hyalex Orthopaedics has received the FDA’s Breakthrough Device designation for the Hyalex Cartilage System.

Advertisement

The cartilage system is meant to repair cartilage defects and restore function in patients who have lost articular cartilage in their knees and require surgery, according to a July 7 press release.

The FDA’s Breakthrough Devices Program allows companies to speed up development, assessment and review of medical devices that are more effective in the treatment or diagnosis of certain diseases and conditions.

Hyalex Orthopaedics is based in Lexington, Mass.

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Is ambulatory care healthcare’s big margin engine? 5 leaders weigh in

Wednesday, July 29
1:00 PM - 2:00 PM CDT

Presenters: Joe Ganley, athenahealthJeffrey Flynn, CASC, Gramercy Surgery CenterBryan Tsao, Access Center, Loma Linda University HealthJason Zepeda, Northridge Hospital Medical Center, CommonSpirit HealthGreg DeConciliis, PA-C, CASC, Boston Out­Patient Surgical Suites

Advertisement

Next Up in Orthopedics / TJR

Advertisement

Comments are closed.